Dental implant surgery has become quite popular with sophisticated surgical techniques such as bone transplants and bone regeneration. Furthermore, rising success rates for these procedures are boosting the industry. As of 2019, the American Dental Association claimed that implant surgeries have a success rate of 95% to 98%. Over 5 million implant procedures are conducted annually in the United States. Before implant implantation, bone grafting helps preserve the existing jaw and raises the odds of successful implant surgery.
Access full Report @ https://www.databridgemarketresearch.com/de/reports/global-dental-membrane-bone-graft-substitute-market
Data Bridge Market Research analyses that the Dental Membrane and Bone Graft Substitute Market market will grow at a CAGR of 9.00% in the forecast period of 2022 to 2029 and is expected to reach USD 1,922.54 million by 2029 from USD 964.86 million in 2021. In some countries, dental membranes and bone graft substitutes are covered by insurance. This makes these products more affordable for patients, which is driving demand. Periodontology is the study of the gums and supporting tissues of the teeth. There is a growing awareness of periodontitis, a chronic inflammatory disease that affects the gums. Dental membranes and bone graft substitutes are often used to treat periodontitis, and this is driving demand for these products.
Growing demand for dental implants is expected to drive the market's growth rate
Dental implants are becoming increasingly popular as a treatment option for missing teeth. Dental membranes and bone graft substitutes are often used in conjunction with dental implants to help promote bone regeneration and ensure successful treatment outcomes. The global population is aging, and this is leading to an increase in the prevalence of dental disorders. Dental membranes and bone graft substitutes are often used to treat dental disorders in older adults, as they are more effective than traditional treatments in this population. There have been significant technological advancements in the field of dentistry in recent years. These advancements have led to the development of new and improved dental membranes and bone graft substitutes. These new products are more effective and have fewer side effects than the older products.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014- 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Dental Membranes, and Dental Bone Grafts), Material (Hydrogel, Collagen, Human Cells Source, Hydroxyapatite, Tricalcium Phosphate, Polytetrafluroethylene), Application (Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, Implant Bone Regeneration, Sinus Lift, Others), End Use (Hospitals, Dental Clinics, Ambulatory Surgical Centers)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Danaher (U.S.), Dentsply Sirona (U.S.), Henry Schein, Inc. (U.S.), Zimmer Biomet (U.S.), Bicon, LLC (U.S.), Adin Global (U.K.), Institut Straumann AG (Switzerland), Sweden & Martina S.p.A. (Sweden), BEGO GmbH & Co. KG (Germany), NEOBIOTECH (South Korea), Neoss Limited (U.K.), ProScan (India), Osstem UK (U.K.), TOV Implant LTD (France), Cortex (Canada), KYOCERA Corporation (Japan), DENTIUM (South Korea) and Alpha-Bio Tec Ltd (Israel)
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
Global dental membrane and bone graft substitute market is categorized into four notable segments which are based on basis of product type, materials, procedure type and end user.
- On the basis of product type, the market is segmented into bone graft substitute and dental membrane. Bone graft substitute segment is expected to dominate the global dental membrane and bone graft substitute market with 67.33% market share as dental bone graft substitutes are mainly used in implantation procedures requiring additional bone support.
- On the basis of materials, the market is segmented into collagen, human cells source, polytetrafluoroethylene (PTFE), hydrogel, hydroxyapatite (HA), tricalcium phosphate (TCP), others. Human cells source segment is expected to dominate the global dental membrane and bone graft substitute market with 50.88% market share. The use of this material in allogeneic bone transplantation and xenotransplantation and in the absorbable membrane of dental membranes increases, contributing to the growth of this segment.
- On the basis of procedure type, the market is segmented into socket preservation, implant bone regeneration, periodontal defect regeneration, ridge augmentation, sinus lift/ sinus augmentation, others. Socket preservation segment is expected to dominate the global dental membrane and bone graft substitute market with 50.32% market share owing to the fact that socket preservation is a procedure to reduce the loss of alveolar bone in the alveolar bone after tooth extraction.
The socket preservation segment will dominate the procedure type segment of the dental membrane and bone graft substitute market
The socket preservation segment will emerge as the dominating segment under procedure type with approximately 68.00% market share. This is because of the growing number of infrastructural development activities in the market especially in the developing economies. Further, growth and expansion of the healthcare industry all around the globe will further bolster the growth of this segment.
- On the basis of end user, the market is segmented into dental clinics, hospitals, ambulatory surgical center, others. Dental clinics segment is expected to dominate the global dental membrane and bone graft substitute market with 58.48% market share due to the increase in the number of elderly patients and the increase in the number of implant operations have led to an increase in the number of bone transplant operations, which is expected to drive the development of this area in the near future.
The dental clinics segment will dominate the end user segment of the dental membrane and bone graft substitute market
The dental clinics segment will emerge as the dominating segment end user segment. This is because of the growing number of dental clinics in the market especially in the developing economies. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.
Major Players
Data Bridge Market Research recognizes the following companies as the major market players: Danaher (U.S.), Dentsply Sirona (U.S.), Henry Schein, Inc. (U.S.), Zimmer Biomet (U.S.), Bicon, LLC (U.S.), Adin Global (U.K.), Institut Straumann AG (Switzerland), Sweden & Martina S.p.A. (Sweden), BEGO GmbH & Co. KG (Germany), NEOBIOTECH (South Korea), Neoss Limited (U.K.), ProScan (India), Osstem UK (U.K.), TOV Implant LTD (France), Cortex (Canada), KYOCERA Corporation (Japan), DENTIUM (South Korea) and Alpha-Bio Tec Ltd (Israel).
Market Development
- In 2021, Institut Straumann, a leading global manufacturer of dental implants, signed an investment agreement with the Shanghai Xin Zhuang Industrial Park to establish its first campus in China. The campus will be a state-of-the-art facility that will house a manufacturing plant, education, and innovation center. The manufacturing plant will produce Straumann's dental implants and other products for the Chinese market. The education center will train dentists and other healthcare professionals on using Straumann's products. The innovation center will focus on developing new products and technologies for the dental market. The establishment of the campus in China is a significant investment by Straumann and reflects the company's commitment to the Chinese market. China is one of the fastest growing dental markets in the world, and Straumann is well-positioned to capitalize on this growth. The campus will help Straumann to meet the growing demand for its products in China and to provide its customers with the best possible service.
- In 2019, BioHorizons, a leading global manufacturer of dental implants, acquired Intra-Lock. Intra-Lock is a privately held company that develops and markets the IntraSpin system, a dental implant system that is designed for better penetration. The acquisition of Intra-Lock will allow BioHorizons to expand its product portfolio and to offer its customers a wider range of options for dental implants. The IntraSpin system is a novel dental implant system that is designed to provide better penetration into bone. The system uses a unique screw-shaped design that allows the implant to self-tap into bone. This makes the implant easier to place and can help reduce the complication risk. The acquisition of Intra-Lock is a strategic move by BioHorizons. The IntraSpin system is a promising new technology that has the potential to improve the success rate of dental implant procedures. The acquisition of Intra-Lock will allow BioHorizons to bring this technology to market and to offer its customers a new and improved option for dental implants.
Regional Analysis
Geographically, the countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in the dental membrane and bone graft substitute market during the forecast period 2022-2029
North America is the dominating region in the global dental membrane and bone graft substitute market. This is due to the high prevalence of dental disorders in the region, as well as the increasing awareness of the condition and the availability of effective treatment options.
Asia-Pacific is estimated to be the fastest-growing region in the dental membrane and bone graft substitute market in the forecast period 2022-2029
Asia-Pacific is expected to grow at the fastest rate of all the regions. The growth of the market in Asia-Pacific is being driven by the increasing prevalence of dental disorders in the region, as well as the growing awareness of the condition and the availability of effective treatment options.
For more detailed information about the dental membrane and bone graft substitute market report, click here – https://www.databridgemarketresearch.com/de/reports/global-dental-membrane-bone-graft-substitute-market
